General Western Blot Reagents
Abcam Dienogest, Steroidal progesterone, 100MG
MW 311.4 Da, Purity >99%. Steroidal progesterone. Non-ethinylated progestin structurally related to testosterone. Anti-androgenic and antiproliferative effects in vitro.
The product is subject to the following: Abcam Restricted Use Statement
Abcam SR 59230A hydrochloride, beta3 adrenoceptor antagonist, 50MG
MW 361.9 Da, Purity >99%. Potent, selective β3 adrenoceptor antagonist (IC50 values are 40, 408 and 648 nM for β3, β1 and β2, respectively). Orally active *in vivo*.
The product is subject to the following: Abcam Restricted Use Statement
Abcam SB 399885 hydrochloride, 5-HT6 antagonist, 50MG
MW 482.8 Da, Purity >99%. Potent, selective competitive 5-HT6 antagonist (pKi values are 8.81 and 9.02 for rat and human native receptors, respectively). Orally active, cognitive enhancer *in vivo*. Displays >200-fold selectivity over 5-HT1A, 5-HT1B, 5-HT1D, 5-HT1E, 5-HT1F, 5-HT2A, 5-HT2B, 5-HT2C, 5-HT4, 5-HT7, α1B, D2, D3, D4 receptors, ion channels and a range of enzymes.
The product is subject to the following: Abcam Restricted Use Statement
Abcam GR113808, selective 5-HT4 antagonist, 10MG
MW 393.5 g/mol, Purity >99%. Potent, highly selective 5-HT₄ receptor antagonist (pKb = 8.8). Displays > 300-fold selectivity over 5-HT₁A, 5-HT₁B, 5-HT₂A, 5-HT₂C and 5-HT₃ receptors. Decreases water intake and potentiates drinking.
The product is subject to the following: Abcam Restricted Use Statement
Abcam CTPB, p300 HAT activator, 1MG
MW 554.1 Da, Purity >99%. Small-molecule p300 histone acetyltransferase (HAT) activator. Benzamide. Active in vitro and in vivo.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Resorufin butyrate, Fluorogenic lipase and cholinesterase substrate, 250MG
MW 283.28 Da, Purity >95%. Fluorogenic lipase and cholinesterase substrate. Fluoresces on hydrolysis. Resorufin methyl ether (ab145372) analog.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Asta x anthin, Antio x idant agent, 25MG
MW 596.8 Da, Purity >97%. Potent antioxidant agent. PPARα agonist and PPARγ antagonist. Free radical scavenger. Reduces oxidative stress. Induces apoptosis. Inhibits NF-κB. Shows anti-inflammatory, antihypertensive, cardioprotective, neuroprotective and antitumor effects in vivo. Orally active.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Coprostanol, Cholesterol derivative, 25MG
MW 388.7 Da, Purity >98%. Cholesterol (ab142501) derivative. Forms from bacterial biohydrogenation of cholesterol. Biomarker for vertebrate intestinal microbe populations in vivo. .
The product is subject to the following: Abcam Restricted Use Statement
Abcam 6-Carbo x yfluorescein N-hydro x ysuccinimide ester, Fluorescent labeling reagent, 10MG
MW 473.39 g/mol. Commonly used fluorescent reagent for labeling of peptides, proteins and nucleotides. Amine-reactive succinimidyl ester carboxyfluorescein which yields carboxyamides that are more resistant to hydrolysis than fluorescein conjugates prepared with FITC.
The product is subject to the following: Abcam Restricted Use Statement
Abcam ACTH (1-24) (human), ACTH/MC2 receptor agonist, 1MG
MW 2933.4 Da. ACTH (1-24) (human), ACTH/MC2 receptor agonist. Achieve your results faster with highly validated, pure and trusted compounds.
The product is subject to the following: Abcam Restricted Use Statement
Abcam (R)-Butaprost, EP2 agonist, 1MG
MW 408.6 Da, Purity >98%. Selective EP2 agonist. PGE2 structural analog. Inhibits chemotaxis (EC50 = 106 nM, maximal effect of PGE2). Increases neutrophil cyclic AMP levels.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Saclofen, GABAB antagonist, 50MG
MW 249.72 Da, Purity >98%. GABAB antagonist Also available in simple stock solutions (ab146704) - add 1 ml of water to get an exact, ready-to-use concentration.
The product is subject to the following: Abcam Restricted Use Statement
Abcam VU0155041 sodium salt, PAM for mGluR4, 50MG
MW 338.2 Da, Purity >98%. Positive allosteric selective modulator at mGluR4 (EC50 values are 798 and 693 nM at human and rat mGluR4 receptors, respectively). It has advantages over PHCCC (ab120043) as it is water soluble and more potent. Shows limited blood-brain barrier permeability. Active in behavioural models of Parkinson's disease following icv injection. Also available in simple stock solutions (ab146686) - add 1 ml of water to get an exact, ready-to-use concentration.
The product is subject to the following: Abcam Restricted Use Statement
![Abcam Anti-FOXA1 antibody [RM1119].](https://assets.fishersci.com/TFS-Assets/CCG/product-images/502711404.JPG-250.jpg)
Abcam Anti-FOXA1 antibody [RM1119].
Anti-FOXA1 antibody [RM1119].
The product is subject to the following: Abcam Restricted Use Statement
